Blue Earth Diagnostics

Blue Earth Diagnostics

Pharmaceutical Manufacturing

About us

Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is a growing international molecular imaging company focused on delivering innovative, well-differentiated diagnostic solutions that inform patient care. Formed in 2014, the Company’s success is driven by its management expertise and supported by a demonstrated track record of rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals. With a clinical focus in cancer, Blue Earth Diagnostics’ expanding pipeline encompasses a variety of disease states, including prostate cancer and neuro-oncology. Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Oxford
Type
Privately Held
Founded
2014
Specialties
Radiopharmaceuticals, Oncology, Prostate Cancer, Molecular Imaging, PET, Medical Imaging, Medical Imaging, Cancer Imaging, Radiology, Nuclear Medicine, and Cancer Diagnostics

Locations

  • Primary

    Magdalen Centre

    The Oxford Science Park

    Oxford, OX4 4GA, GB

    Get directions
  • 259 Prospect Plains Rd

    Monroe Township, New Jersey 08831, US

    Get directions

Employees at Blue Earth Diagnostics

Updates

Similar pages

Browse jobs

Funding

Blue Earth Diagnostics 1 total round

Last Round

Series B

US$ 27.9M

See more info on crunchbase